Trials / Completed
CompletedNCT01425411
Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Mustafa Kemal University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan | 80/160 mg dosage of valsartan or 160+12,5 mg valsartan+hydrochlorothiazide combination, once a day, for six months |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2011-08-30
- Last updated
- 2011-08-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01425411. Inclusion in this directory is not an endorsement.